entity

Amyloid Clearance

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Amyloid Clearance: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
4Hypotheses
4Analyses
1Outgoing
5Incoming

Wiki Pages (20)

Knowledge base pages for this entity

Sleep and Circadian Dysfunction in Alzheimer's Disease

mechanism · 8066 words

nhp-validation-animal-model

general · 5820 words

Neuroresilience Mechanisms and Evidence

mechanism · 5775 words

neuroinflammation

mechanism · 5462 words

Alzheimer's Disease

disease · 5265 words

Outgoing (1)

TargetRelationTypeStr
Disease Progressionmodulatesprocess0.85

Incoming (7)

SourceRelationTypeStr
Donanemabpromotesdrug0.95
Anti-Amyloid-beta Monoclonal Antibodiesmodulatesdrug0.90
TIM-3inhibitsprotein0.85
Trem2 Agonismactivatesmechanism0.80
Glymphatic Clearanceinvolved_inprocess0.80

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.588 neurodegeneration How does APOE4's beneficial immune funct
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.576 neurodegeneration What are the cell-type-specific transcri
Test: TREM2 enhances amyloid clearance 0.405 - -
Microglial ACE Enhancement for Amyloid Clearance 0.399 neurodegeneration Gene expression changes in aging mouse b

Mentioning Analyses (4)

Scientific analyses that reference this entity

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.444

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

synaptic biology | 2026-04-07 | 0 hypotheses

APOE4 structural biology and therapeutic targeting strategies

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.595

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clin [PMID:41324786] Abushakra S, Doraiswamy PM, Hey JA, Tosu CNS drugs 2026 0
Adverse childhood experiences and cardiometabolic risk factors in people with bi [PMID:40935250] Turner A, Kuperberg M, McGovern H, Wrobe J Affect Disord 2026 0
Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomark [PMID:41198173] Prasad R, Adu-Rutledge Y, Ziani B, Floyd Gut 2026 0
Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease. [PMID:41329157] Smyth LCD, Verhaege D, Standen-Bloom E, J Exp Med 2026 0
A minimally invasive dried blood spot biomarker test for the detection of Alzhei [PMID:41491101] Huber H, Montoliu-Gaya L, Brum WS, Vávra Nat Med 2026 0
[Polypharmacy and nephrotoxicity]. [PMID:41535444] Czock D, Ebinger K, Sommerer C Inn Med (Heidelb) 2026 0
Association between sleep duration and fluid biomarkers of Alzheimer's disease: [PMID:41610733] Young VM, Zeynoun J, Ruiz Laza A, Salard Sleep Med Rev 2026 0
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. [PMID:41618732] Kantarci K, Kara F, Tosakulwong N, Fough Alzheimers Dement 2026 0
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean comm [PMID:41691306] Orellana P, Henríquez F, Cabral-Miranda Alzheimers Res Ther 2026 0
Neuro-renin-angiotensin-aldosterone system axis in alzheimer's disease: from mol [PMID:41706377] Singh G, Maparu K, Aran KR Metab Brain Dis 2026 0
Renin-angiotensin system blockade attenuates brain mitochondrial dysfunction, ox [PMID:41883437] García Menéndez S, Inserra F, de Cavanag World J Exp Med 2026 0
Association Between ACE (I/D) Polymorphism and Essential Hypertension (EH): An U [PMID:41899774] Smallwood A, Akam E, Hunter DJ, Singh M, Int J Environ Res Public Healt 2026 0
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR): a rand [PMID:41932694] Pepine CJ, Handberg E, Cooper-DeHoff R, Open Heart 2026 0
Renin-Angiotensin-Aldosterone Medication Use and Outcomes in Injured Patients Re [PMID:41936145] Werenski HE, Diz DI, Chappell MC, Hoth J J Surg Res 2026 0
Characteristics of reproductive tract microbiota in health and disease. [PMID:41936969] Han Q, Wang N, Feng T, Li YY, Zhu Z et a Microb Pathog 2026 0
Novel_circ_002651 regulates the immune defense of eastern honeybee larvae agains [PMID:41940497] Zhang K, Wang F, Fan N, Fan X, Wu T et a Virulence 2026 0
Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults wi [PMID:41945136] Dankishiya FS, Muhammad H, Wudil UJ, Mus Naunyn Schmiedebergs Arch Phar 2026 0
Ace in the hole: playing cards show the role of order and magnitude in the SNARC [PMID:41945148] Mingolo S, Prpic V, Cipora K, Bilotta E, Psychol Res 2026 0
Feasibility of implementing an auditory rehabilitation program for older adults [PMID:41945417] Torrente MC, Vasquez C, Bravo R, Miranda Acta Otolaryngol 2026 0
Spatial distribution and health risk assessment of heavy metals in soils around [PMID:41954659] Tengbeh AS, Akande IO, Offor CC, Abdulai Environ Geochem Health 2026 0